Curriculum Vitae

ASSOCIATE PROF. DR. KOH ONG HUI

Associate Professor
  • Department of Psychological Medicine
    Faculty of Medicine
  • +603-79492068

AREAS OF EXPERTISE


  • EARLY PSYCHOSIS
  • PSYCHOSOCIAL REHABILITATION AND COMMUNITY PSYCHIATRY

ACADEMIC QUALIFICATION


  • MPSYCMED(UM)(2004), (Psychological Medicine)
    Universiti Malaya (UM)
  • MBBS(INDIA)(1996), (Perubatan dan Pembedahan)
    Manipal Academy of Higher Education (Mahe), India

ADMINISTRATIVE DUTIES


  • Coordinator for Centre For Injury Research, Faculty of Medicine, University Malaya
    01 Jan 2006 - present (Department of Psychological Medicine, Faculty of Medicine)
  • Coordinator of Ward 3TE Menara Timur
    01 Apr 2008 - present (Department of Psychological Medicine, Faculty of Medicine)
  • Acting Head of Department
    09 Oct 2023 - 12 Oct 2023 (Department of Psychological Medicine, Faculty of Medicine)
  • Acting Head of Department
    01 Oct 2022 - 31 Oct 2022 (Department of Psychological Medicine, Faculty of Medicine)
  • Coordinator
    01 Mar 2021 - 31 Dec 2021 (Department of Psychological Medicine, Faculty of Medicine)
  • Coordinator
    30 Nov 2017 - 30 Nov 2018 (Department of Psychological Medicine, Faculty of Medicine)
  • Acting Head of Department
    18 Jun 2017 - 30 Jun 2017 (Department of Psychological Medicine, Faculty of Medicine)
  • Acting Head of Department
    17 Sep 2010 - 23 Sep 2010 (Department of Psychological Medicine, Faculty of Medicine)
  • Head of Department
    20 May 2009 - 22 May 2009 (Department of Psychological Medicine, Faculty of Medicine)
  • Head of Department
    06 Apr 2009 - 06 Apr 2009 (Department of Psychological Medicine, Faculty of Medicine)

MEMBERSHIPS


  • AHLI KLUSTER PERUBATAN DAN SAINS KESIHATAN , MEMBER
    Since 2022 (National)
  • LIFE MEMBER OF INTERNATIONAL EARLY PSYCHOSIS ASSOCIATION (IEPA), MEMBER
    Since 2008 (International)
  • MALAYSIAN PSYCHIATRIC ASSOCIATION, MEMBER
    Since 2007 (National)

AWARD AND STEWARDSHIP


  • Best Neuroscience Publication Awards for year 2021 (Year of Award 2023)
    University Malaya, 2023 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2022 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2019 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2018 (University)
  • Certificate of Achievement for screening and randomising the First Subject in Malaysia and Asia Pacific for Aspire 1 study
    Johnson & Johnson, 2017 (International)
  • STAR Recruiter-Q2 2017 IN BRILLIANT STUDY
    Sumitomo Dainippon Pharma Co., Ltd, 2017 (International)
  • Certificate of Appreciation for a remarkable effort in Psychiatry in Action Workshop
    MSD, 2015 (International)
  • Star Recruiter Award Q3 2015
    Sumitomo Dainippon Pharma Co. Ltd, 2015 (International)
  • Extraordinary achievement at D1002001 Rater Refresher
    Bracket, 2015 (International)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2014 (University)
  • Award of Excellence 2009 for clinical trials
    Department of Psychological Medicine, University of Malaya, 2009 (Department)
  • 2nd Prize for Eli Lilly Neuroscience Post Graduate Inter-University competition
    Eli Lilly, 2008

PUBLICATIONS


Article in Journal
WoS
  1. Miqdadi, Ahmad I.; Chong, Mei-Chan; Yoong, Tang Li; Koh, Ong-Hui; Alhadidi, Majdi (2024). Internet-Based Cognitive-Behavioral Therapy for Individuals Experiencing Panic Attacks A Scoping Literature Review, JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES. . doi:10.3928/02793695-20230919-02
  2. Sabki, Zuraida Ahmad; Kim, Lee Hui; Danaee, Mahmoud; Sulaiman, Ahmad Hatim; Razali, Khairul Arif; Koh, Ong Hui; Kanagasundram, Sharmilla; Kaur, Manveen; Azhar, Fatin Liyana; Francis, Benedict (2023). Assessment of Psychometric Properties of the Malay Version of the Brief Resilience Scale (BRS-M) among Non-Academic Staff Working from Home during COVID-19 in Malaysia, HEALTHCARE. 11(8). doi:10.3390/healthcare11081146
  3. Zaini, S., Sulaiman, A. H., Huri, H. Z., Koh, O. H., Gill, J. S., Francis, B., . . . Guan, N. C. (2021). Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana, 50(1), 161-170. doi: 10.17576/jsm-2021-5001-16
  4. Damodaran, I., Hui, K. O., Nordin, A. S. A., Yee, A., Gill, J. S., Francis, B., . . . Sulaiman, A. H. (2020). An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. Healthcare, 8(4), 13. doi: 10.3390/healthcare8040533
  5. Kaur, K., Sulaiman, A. H., Yoon, C. K., Hashim, A. H., Kaur, M., Hui, K. O., . . . Gill, J. S. (2020). Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. International journal of environmental research and public health, 17(18), 22. doi: 10.3390/ijerph17186730
  6. Subermaniam, K., Yow, Y. Y., Lim, S. H., Koh, O. H., & Wong, K. H. (2020). Malaysian macroalga Padina australis Hauck attenuates high dose corticosterone-mediated oxidative damage in PC12 cells mimicking the effects of depression. Saudi Journal of Biological Sciences, 27(6), 1435-1445. doi: 10.1016/j.sjbs.2020.04.042
Scopus
  1. Ahmad Sabki Z., Kim L.H., Danaee M., Sulaiman A.H., Razali K.A., Koh O.H., Kanagasundram S., Kaur M., Azhar F.L., Francis B. (2023). Assessment of Psychometric Properties of the Malay Version of the Brief Resilience Scale (BRS-M) among Non-Academic Staff Working from Home during COVID-19 in Malaysia, Healthcare (Switzerland). 11(8). doi:10.3390/healthcare11081146
Others
  1. Francis, B; Gill, JS; Sulaiman, AH; Petrus, CF; Koh, OH. (2019).The antipsychotic property of neoadjuvant chemotherapy regime 5-flourouracil, epidoxorubicin and cyclophosphomide (FEC) in a patient with treatment resistant schizophrenia: a case study. European Psychiatry, 56 S69-S69
  2. Koh Ong Hui. Prucalopride for the Treatment of Clozapine Induced Constipation: A Case Report. JOJ Case Stud. 2018; 6(2): 003 555683. DOI: 10.19080/JOJCS.2018.06.555683
  3. Lee AMH, Ng CG, Koh OH, Gill JS et al. Metabolic Syndrome in First Episode Schizophrenia, Based on the National Mental Health Registry of Schizophrenia (NMHR) in a General Hospital in Malaysia: A 10-Year Retrospective Cohort Study. International Journal of Environmental Research and Public Health. 15(5):933 May 2018
  4. Ng Su Huey, Ng Chong Guan, Jesjeet Singh Gill, Koh Ong Hui, Ahmad Hatim Sulaiman, Sharmilla Kunagasundram. (2018) Core Symptoms of Major Depressive Disorder among Palliative Care Patients. Int. J. Environ. Res. Public Health,15,1758
  5. Syahrir Zaini, Harvin Anbu Manivanna Bharathy, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan. (2018).Development of a Strategic Tool for Shared Decision-Making in the Use of Antidepressants among Patients with Major Depressive Disorder: A Focus Group Study. Int. J. Environ. Res. Public Health 2018, 15(7), 1402
  6. Ng Chong Guan, Loh Huai Seng, Anne Yee Hway Ann, Koh Ong Hui. Factorial Validity and Reliability of the Malaysian Simplified Chinese Version of Multidimensional Scale of Perceived Social Support (MSPSS-SCV) Among a Group of University Students.Asia Pacific Journal of Public Health 2015, Vol. 27(2): 225-231
  7. Chong Guan Ng, Lee Khing Tan, Jesjeet Singh Gill, Ong Hui Koh, Stephen Jambunathan, Subash Kumar Pillai & Hatta Sidi. Reliability and validity of the Malay version of Attitudes toward Lesbians and Gay Men (MVATL/MVATG): A study on a group of medical students in Malaysia. Asia_Pacific Psychiatry 5 (2013) 118 122.
  8. Koh Ong Hui, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Subash Kumar Pillai, Stephen Thevanathan Jambunathan, Rusdi Abdul Rashid. A 3-Week, Open Label Study to Evaluate The Efficacy and Safety of Extended Release Quetiapine Fumarate in The Treatment of Agitation in Patients with Schizophrenia. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013;23(1):14-23
  9. NgCG, Koh OH, GillJS 2013. Methylphenidate for the treatment of erectile dysfunction induced by long acting injectable paliperidone palmitate: a case report. Bulletin of Clinical Psychopharmacology 23(4):361-364.
  10. R. Manikam , S.T. Jambunathan, S.K. Pillai, J.S. Gill , K.O. Hui. 2012. New-Onset Refractory Status Epilepticus Syndrome (NORSE), Early-Onset Schizophrenia and Possesion: A Clinical Dilemma in the Multicultural Asian Emergency Department Setting. The Internet Journal of Emergency Medicine. 7(2)
  11. Jesjeet Singh Gill, Subash Kumar Pillai, Koh Hui Ong , Stephen Jambunathan, Rosy Jawan. 2011. Mania secondary to a right arteriovenous malformation. Asia-Pacific Psychiatry 3(3):160 161
  12. Jesjeet Singh Gill, Subash Kumar Pillai, Ong Hui KOH and Stephen Thevanathan JambunaTHan. Low dose Quetiapine in the Treatment of an Adolescent with Somnambulism:A Case Report. Acta Neurologica Belgica.2011, 111, 155-156
  13. J.S. Gill, L. Hong Gee, T. Jing Wen, J. Tan, K. Ong Hui, R. Jawan. Adherence to metabolic monitoring guidelines in atypical antipsychotic usage. International Journal of Neuropsychopharmacology. Vol. 13 (S1): 92-93.
  14. Jambunathan ST, Gill J, Ong Hui Koh, Sulaiman H. 2010 Parkinson Disease and Neuroleptic Withdrawal. Annals of General Psychiatry 2010;9(S1):S223
  15. Jesjeet S Gill, Koh OH, Subash K Pillai. Anxiety Disorders among Incarcerated Drug Users. Malaysian Journal of Psychiatry online early.
  16. Jesjeet Singh Gill, Rusdi Abdul Rashid, Koh Ong Hui, Rosy Jawan. 2010. History Of Illicit Drug Use In Malaysia-A Review. International Journal Of Addiction Sciences Online Early
  17. Jesjeet Singh Gill, Subash Kumar Pillai, Ong Hui Koh, Stephen Jambunathan. 2010. Non-fatal Paliperidone Overdose: A Case Report. Turkish Journal Of Psychiatry 21(4): 331-334
  18. K Kannan, S K Pillai, J S Gill, K O Hui, V Swami.2010.Religious beliefs, coping skills and responsibility to family as factors protecting against deliberate self-harm. South African Journal Of Psychiatry 16(4):138-146
  19. Koh OH, Azreen Hashim N, Jesjeet S Gill, Subash K Pillai.2010. A Case of Post-Stroke Mania.
  20. Koh OH, Gill JS, Pillai SK 2010. Evidence-Based Clinical Practice - A Critical Analysis Of Its Justification And Limitations. MJP Online Early
  21. Koh OH, Jesjeet SG, Pillai SK. 2010. BOOK REVIEW. SCHIZOPHRENIA-BIOPSYCHOSOCIAL APPROACHES AND CURRENT CHALLENGES (SECOND EDITION) EDITED BY SIEGFRIED KASPER AND GEORGE N. PAPADIMITRIOU, INFORMA HEALTHCARE UK LTD. LONDON 2009, 386 PAGES
  22. Koh OH, Ng CG, Aida SA, Aizura SA, Salina M, Nor Zuraida Z.2010. Bipolar disorder presented with postnatal depression and its associated factors among a group of women attending the postnatal clinic, University Malaya Medical Centre - a cross sectional study. Bipolar Disorders Volume 12, Supp 1, March 2010
  23. N.Z. Zainal, J.S. Gill, O.H. Koh, H. Lockman, A.H. Hashim. Naturalistic observation on effects of antipsychotics on psychopathology and functionality of schizophrenia patients in a single centre in Malaysia. International Journal of Neuropsychopharmacology. Vol. 13 (S1): 113
  24. O.H. Koh, G. Jesjeet Singh, P. Subash Kumar, J.T. Tan, J. Stephen. Choice of antipsychotics prescribed for first episode psychotic patients in a teaching hospital. International Journal of Neuropsychopharmacology. Vol. 13 (S1): 98
  25. Tan CL, Anne Yee HA, Majid SM, Koh OH, Ng CG. 2010. Antidepressant induced Mania and Steroid Psychosis in a Patient with Bell s Palsy. Malaysian Journal of Psychiatry Online Early
  26. Validation of the Malay version of the Multidimensional Scale of Perceived Social Support (MSPSS-M) among a group of medical students in Faculty of Medicine, University Malaya. Asian Journal of Psychiatry Online.
  27. J.S. Gill, S.T. Jambunathan, J.H. Ting, O.H. Koh, N.Z. Zainal. The pattern of use and outcome of Asian patients with schizophrenia treated with risperidone over five years. The Journal of the European College of Neuropsychopharmacology Vol. 19, S3, Pg. 558
  28. Ng CG*, Aida SA*, Aizura SA**, Salina M*, Nor Zuraida Z*, Koh OH* Bipolar Disorder and Other Associated Factors in Postnatal Depression. Malaysian Journal of Psychiatry Online Early
  29. Ng CG, Aida SA, Aizura SA, Salina M, Nor Zuraida Z, Koh OH. Bipolar Disorder and other Associated Factors in Postnatal Depression. Malaysian Journal of Psychiatry. 18(2)
  30. Ng CG, Amer Siddiq AN, Aida SA, Koh OH, Nor Zuraida Z. 2009. Reliability Of Malay Version Of List Of Threatening Experiences Questionnaire: A Study On A Group Of Medical Students In Malaysia. Malaysian Journal of Psychiatry eJournal. Vol. 18 No. 2
  31. Ng CG, Amer Siddiq AN, Salina M, Koh OH, Zuraida NZ Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur.2009. Early Readmissions in Patients after Electroconvulsive Therapy in a University Hospital Setting-A Retrospective Study. MJP Online Early 2009
  32. OH,Koh. 2009. Antiepileptic drugs to treat psychiatric disorders. Malaysian Journal of Psychiatry
  33. Zuraida NZ, Gill JS, Koh OH, Kanagasundram S, Saniah AR, Sapini Y, Salina M, Zuraida A Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Gender Influences on Psychopathology and Functionality in Schizophrenia in University Malaya Medical Centre, Kuala Lumpur, Malaysia. MJP Online Early
  34. AN Amer Siddiq, CG Ng, Koh Ong Hui, SA Aida, JS Gill, ST Jambunathan and H Habil, "Early Intervention Center (EIC) in the screening for bipolar disorder in Malaysia", 2008, Bipolar Disord, Vol. 10, No. S1, pg. 30-31
  35. Koh Ong Hui, NA Hashim, JS Gill, "Post Stroke Mania: A Case Report", 2008, Bipolar Disord, Vol. 10, No. S1, pg. 48
  36. OH Koh. 2008. Book Review on Antiepileptic Drugs To Treat Psychiatric Disorders. e-Malaysian Journal of Psychiatry online
  37. Stephen T Jambunathan, Jesjeet Singh Gill, Sharmilla Kanagasundram, Koh Ong Hui. Dissociative Identity Disorder: An Attempt to Understand the Disorder in Malaysian Context.
  38. Amer Siddiq, Koh Ong Hui, Nor Zuraida Zainal, Jesjeet Singh Gill, \"Phenomenological Ethnic Differences in First Episode Schizophrenia Spectrum Disorder Patients\", 2007, Australian and New Zealand Journal of Psychiatry, Vol. 41, no. Suppl. 2, pg. 487
  39. Nor Zuraida Zainal, Koh Ong Hui, Ting Joe Hang, Anita Bustam, "Prevalence of distress in Cancer Patients Undergoing Chemotherapy", 2007, Asia-Pacific Journal of Clinical Oncology
  40. KOH ONG HUI "FIRST EPISODE PSYCHOSIS IN A MALAYSIAN CHINESE POPULATION" Hong Kong Journal of Psychiatry 15 2006
  41. NOR ZURAIDA ZAINAL KOH ONG HUI TING JOE HANG "PSYCHOSOCIAL PROBLEMS AND DISTRESS IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY" , Journal of the Psychological, Social and Behavioral Dimensions of Cancer 15 2 2006
  42. NOR ZURAIDA ZAINAL, TING JOE HANG, KOH ONG HUI "EMOTIONAL AND PHYSICAL PROBLEMS IN RELATION TO PSYCHOLOGICAL DISTRESS IN BREAST CANCER PATIENTS UNDERGOING CHEMOTHERAPY" , Journal of the Psychological, Social and Behavioral Dimensions of Cancer 15 2 2006
  43. KOH ONG HUI "ETHNIC DIFFERENCES IN PHENOMENOLOGY OF FIRST EPISODE PSYCHOSIS. ", SCHIZOPHR RESEARCH 70 1 2004
  44. KOH ONG HUI "FIRST EPISODE PSYCHOSIS CULTURAL DIFFERENCES IN MALAYSIA. ", SCHIZOPHRENIA RESEARCH 70 1 2004
  45. Koh Ong Hui "Reasons for Staying Alive in suicide attempters across different ethnic groups admitted to UMMC.", 2002, Malaysian Journal of Psychiatry, Vol. 10, no. 2, pg. 40
Books
  1. Ong Hui Koh, Ng Chong Guan, Subash Kumar Pillai. 2012. Characteristics of Patients Presenting with First Episode Psychosis. A Multicultural Perspective of Early Psychosis. Lambert Academic Publishing
  2. Koh Ong Hui. 2011. Chapter 8-Bipolar Disorder and Depression from Perpectives of Addiction Medicine in Malaysia.
  3. Prof. Dr. Maniam. Thambu, Koh Ong Hui et al "Malaysian Consensus Statement for the Treatment of Bipolar Disorder", 2007, Malaysian Consensus Statement for the Treatment of Bipolar Disorder
Chapter in Books
  1. Ng CG, AH Sulaiman, JS Gill, Koh OH& Salina Mohamed. (2017) Psychiatric Emergency Handbook for Medical Students Second Edition.
Article in Proceeding
  1. Subash Kumar Pillai, Jesjeet Singh Gill, Ong Hui Koh, Stephen Thevanathan Jambunathan. Polypharmacy in the treatment of schizophrenia. Proceeding for 23rd European College Of Neuropsychopharmacology conference, Amsterdam, The Netherlands P.3.a.301
Other Publications
  1. Koh Ong Hui. 2010. The Formation of the Malaysian Chapter of ISBD. ISBD Global Vol. 11, Issue 1, Winter page 3-4 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  2. Ting Joe Hang, Nor Zuraida Zainal, Koh Ong Hui, "Pain and Emotional Problems in Cancer Patients Undergoing Chemotherapy in Malaysia", 2007, Psychooncology, Vol. 16, pg. S159, IPOS 9th World Congress - Extended Abstract
  3. Case report on Bipolar Affective Disorder "Koh Ong Hui", Medical Grapevine Magazine, 2006 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  4. SeCoST Bulletin Report "OH Koh, Hussain Habil, JH Ting", "Lain-Lain", "2006 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)

RESEARCH INTEREST


  • Liaison Psychiatry
  • Early Psychosis

RESEARCH PROJECT


National
  1. 2010 - 2011, Janssen-Cilag, a division of Johnson & Johnson Sdn Bhd
    Safety, Tolerability, and Treatment Response of Paliperidone Palmitate in Subjects with Schizophrenia When Switching from Oral Antipsychotics ( Consultant)
  2. 2007 - 2008, Peruntukan Jangkamasa Pendek
    Validation of the Malay Version of Two Psychiatric Questionnaires ( Co-Inventor)
International
  1. 2016 - 2019, International Funding
    An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression ( Consultant)
  2. 2009 - 2018, Otsuka Pharmaceutical Development and Commercialization. Inc
    An open label, multicenter, rollover, long-term study of Aripiprazole intramuscular depot in patients with schizophrenia ( Consultant)
  3. 2017 - 2018, International Funding
    A Double-Blind, Randomized, Placebo-controlled Study to evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide ( Consultant)
  4. 2015 - 2017, Dainippon Sumitomo
    A long term study of SM-13496 in patients with Bipolar 1 Disorder ( Consultant)
  5. 2017 - 2017, International Funding
    A Double-Blind, Placebo-Controlled Study of MO-214 in patients with Schizophrenia ( Consultant)
  6. 2015 - 2016, Boehringer Ingelheim
    A phase II randomised, double-blinded, placebo- controlled study to evaluate the efficacy, safety and tolerability of four orally administered doses of BI 409306 during a 12- week treatment period in patients with schizophrenia on stable antipsychotic treatment ( Consultant)
  7. 2015 - 2016, Sumitomo Dainippon Pharma Co., Ltd
    D4904020: Confirmatory Phase 3 Study of DSP-5423P in Patients with Schizophrenia ( Consultant)
  8. 2014 - 2016, Dainippon Sumitomo
    A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for the Treatment of Bipolar I Depression (Phase III) ( Consultant)
  9. 2015 - 2016, Otsuka Pharmaceutical Development and Commercialization. Inc
    A long-term, phase 3, multicenter, open-label trial to evaluate the safety and tolerability of oral OPC-34712 as maintenance treatment in adults with schizophrenia ( Consultant)
  10. 2014 - 2016, Sunovion Pharmaceuticals
    A 104 -week, flexible dose, open label, multicenter extension study to evaluate the long term safety and effectiveness of Lurasidone in Paediatric subjects with schizophrenia ( Consultant)
  11. 2014 - 2016, Alkermes
    A phase 3, multicenter, extension study of ALK 9072-003 Ext 2 to assess the long-term safety and durability of effect of ALKS 9072 in subjects with stable schizophrenia ( Consultant)
  12. 2014 - 2015, Lundbeck
    A multicentric multi country cross sectional study in Asian population to assess and describe cognitive dysfunction in Major Depressive Disorder ( Consultant)
  13. 2015 - 2015, Servier
    Efficacy and safety of Tianeptine oral administration in elderly patients suffering from MDD ( Consultant)
  14. 2015 - 2015, Otsuka Pharmaceutical Development and Commercialization. Inc
    A Multicenter, randomized, double-blind trial to assess the efficacy and safety of ASC-01 in patients with Major Depressive Disorder ( Consultant)
  15. 2014 - 2014, Lundbeck
    A multicentric multi country cross sectional study in Asian population to assess and describe cognitive dysfunction in Major Depressive Disorder ( Consultant)
  16. 2009, Takeda
    A randomized, double-blind, parallel-group, placebo-controlled, fixed dose study comparing the efficacy and safety of 3 doses of Lu AA21004 in acute treatment of adults with Major Depressive Disorder ( Consultant)
  17. 2006 - 2008, Servier
    Efficacy and safety of Agomelatine with Flexible Dose given Orally for 8 Weeks in Outpatients with Major Depressive Disorder ( Consultant)
  18. 2008, Lundbeck
    Randomised, double-blind, parallel-group, placebo-controlled, duloxetine-referenced, dose-finding study of Lu AA24530 in Major Depressive Disorder ( Consultant)
  19. 2008 - 2008, Forest Research Institute
    Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia ( Consultant)
  20. 2008 - 2008
    A randomised double-blind, placebo and active controlled, parallel group study to evaluate the efficacy and safety of 3 fixed doses of JNJ-37822681 administered twice daily in subjects with schizophrenia. ( Consultant)
  21. 2002 - 2007, Lundbeck
    Sertindole versus Risperidone efficacy and tolerability study Clinical trial ( Consultant)
  22. 2006 - 2007, Astra Zeneca
    A 6-week, International, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase IIIb Study of the Efficacy and Safety of Quetiapine Fumarate Immediate Release Tablets in the Treatment of Adolescents with Schizophrenia ( Consultant)
  23. 2006 - 2007, Astra Zeneca
    A Multi-Centre, Double-Blind, Randomized, Parallel Group and Active Controlled Phase lll Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release as Monotherapy in the Treatment of Adult Patients with Major Depressive Disorder (AMBER Study) ( Consultant)
  24. 2006 - 2007, Lundbeck
    Double blind, Randomised, Placebo-controlled Study comparing the efficacy and safety of two fixed doses of a novel Antidepressant compound to that of placebo in patients with Major Depressive Disorder ( Consultant)
  25. 2006 - 2007, Janssen Cilag
    RIS-BMN-3001 Randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Risperidonelong-acting injectable for the prevention of mood episodes in the treatment of subjects with bipolar 1 disorder ( Consultant)
  26. 2007 - 2007, Janssen Cilag
    Functionality in Schizophrenia Project: Personal and Social Performance ( Consultant)
  27. 2007 - 2007, Janssen Cilag
    Use of Structured Clinical Interview to Recognize and Diagnose Schizoaffective Disorder ( Consultant)
  28. 2007 - 2007, Janssen Cilag
    Randomized Double Blind Placebo Controlled Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Paliperidone Palmitate in Subjects with Schizophrenia ( Consultant)
  29. 2007, Janssen Cilag
    A randomized double blind, placebo and active controlled, parallel group study to evaluate the efficacy and safety of risperidone long acting injectable for the prevention of mood episodes in the treatment of subjects with bipolar 1 disorder ( Consultant)
  30. 2007, Lundbeck
    Lundbeck Study11613A double blind randomised parallel group, placebo controlled study of the safety tolerability and efficacy following sequential doses of Lu 31-130 to male patients with schizophrenia ( Consultant)
  31. 2007 - 2007, Sanofi-Aventis
    EFC6224/ALBERIO Multi Center double blind placebo controlled parallel group fixed dose efficacy and safety study of SR58611A 350mg twice daily vs. placebo in adults with Major Depressive Disorder on concomitant treatment with escitalopram 10mg/day ( Consultant)
  32. 2007, Janssen Cilag
    Janssen RO 76477-SCA 3002 Randomised, Double Blind Placebo controlled parallel group Study to evaluate the efficacy and safety of flexible dose Paliperidone ER in the treatment of subjects with Schizoaffective Disorder ( Consultant)
  33. 2007, Sanofi Aventis
    Efficcacy and safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a sub-study of the effect of M100907 on stable Type ll Diabetes Mellitus: a One year, multi-center, randomised, double-blind, placebo-controlled study ( Consultant)
  34. 2007, Janssen Cilag
    PERFECT Study SCH3022 ( Consultant)
  35. 2007, Janssen Cilag
    R092670-PSY-1008 open label, long-term, multiple dose, safety and tolerability, pharmacokinetic study of 150mg eq. Paliperidone palmitate in the treatment of subjects with schizophrenia ( Consultant)
  36. 2007, Sanofi Aventis
    Efficcacy and safety of 2mg/day of M100907 on Sleep Maintenance Insomnia with a sub-study of the effect of M100907 on stable Type ll Diabetes Mellitus: a 12 week, multi-center, randomised, double-blind, placebo-controlled study ( Consultant)
  37. 2005 - 2006, Pfizer
    Ziprasidone versus Olanzapine efficacy and tolerability study ZODIAC clinical trial ( Consultant)
  38. 2005 - 2006, Astra Zeneca
    Efficacy of Monotherapy of Seroquel in Bipolar Mania SPaRCLe clinical study ( Consultant)
  39. 2005 - 2006, Astra Zeneca
    Efficacy of Monotherapy Seroquel on Bipolar Depression (EMBOLDEN) Study ( Consultant)
  40. 2005 - 2006, Janssen Cilag
    A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response Study to Evaluate the Efficacy & Safety of Paliperidone Palmitate in Subjects with Schizophrenia. ( Consultant)
  41. 2005 - 2006, Pfizer-Organon
    A Phase III, Randomized, Placebo-Controlled, Double Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs Olanzapine & Placebo in In-Patients with Acute Mania ( Consultant)
  42. 2005 - 2006, Janssen Cilag
    A randomized, Double Blind, Active and Placebe-controlled, Parallel group, Multicenter study to evaluate the efficacy and safety of Extended Release Paliperidone as a maintenance treatment after an acute Manic or Mixed Episode associated with Bipolar 1 Disorder ( Consultant)
  43. 2005 - 2006, Janssen Cilag
    A randomized, Double Blind, Active and Placebe-controlled, Parallel group, Multicenter study to evaluate the efficacy and safety of Extended Release Paliperidone as a maintenance treatment after an acute Manic or Mixed Episode associated with Bipolar 1 Disorder ( Consultant)
  44. 2006 - 2006, Astra Zeneca
    A 6-week Multicenter, International, Randomized, Double-Blind, Parallel group. Placebo controlled, Phase 111B Study of Efficacy and safety of Quetiapine Fumarate Immediate Release Tablets in daily doses of 400mg and 800mg compared with placebo in the treatment of adolescents with Schizophrenia ( Consultant)
University
  1. 2007 - 2007
    Prevalence of Depression in patients with CCF with erectile dysfunction ( Consultant)

CONSULTANCY PROJECT


  • Aspire Protocol 31-10-270 Aspire Long Term Extension Study, Otsuka
    01 Apr 2011 - 01 Apr 2018 (International)
  • A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3-Month Formulation for The Treatment of Subjects With Schizophrenia, Johnson and Johnson
    01 Oct 2012 - 01 Oct 2013 (International)
  • A Phase 2 Randomized Double-Blind, Placebo Controlled Study to Evaluate The Effect of Add-On Amg 747 On Schizophrenia Negative Symptoms, Amgen Inc.
    01 Sep 2012 - 01 Sep 2013 (International)
  • An Open-Label, Prospective, Non-Comparative Study to Evaluate The Efficacy and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia, Johnson and Johnson
    01 Aug 2012 - 01 Aug 2013 (International)
  • Alk9072-003 a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy and Safety of Alks 9072 in Subjects With Acute Exacerbation of Schizophrenia, INC Research
    01 Jun 2012 - 01 Jun 2013 (International)
  • A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Fixed Dose Opc-34712 (4, 2 and 1 Mg/Day) in The Treatment of Adults With Acute Schizophrenia, Otsuka
    01 Jun 2012 - 01 Jun 2013 (International)
  • A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess The Pharmacokinetics, Safety, Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia., Johnson and Johnson
    01 Apr 2012 - 01 Apr 2013 (International)
  • A Phase 3 Multicenter Extension Study to Evaluate The Safety of Alks 9072, INC Research
    01 Jan 2013 - 01 Jan 2013 (International)
  • A Multicenter, Randomized, Double-Blind Study to Evaluate The Efficacy, Safety and Tolerability of An Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder., Otsuka
    01 Jun 2011 - 01 Jun 2012 (International)
  • Asia Zoom Antidepressants Study, Cegedim
    01 Apr 2012 - 01 Apr 2012 (National)
  • Refresh Study to Assess The Efficacy of Rp5063 Administered to Subjects With An Acute Exacerbation of Schizophrenia or Schizoaffective Disorder., Reviva Pharmaceuticals
    01 Apr 2012 - 01 Apr 2012 (International)
  • A Long Term Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy, Safety and Tolerability of Aripiprazole (Opc-14597) as Maintenance Treatment in Adolescents Patients With Schizophrenia., Otsuka
    01 Apr 2012 - 01 Apr 2012 (International)
  • A Multicenter, Active-Controlled, Double-Blind, Parallel Group-Comparison Trial to Investigate The Efficacy and Safety of Aripiprazole Im Depot (Opc-145971md) Compared With Aripiprazole Tablets in Patients With Schizophrenia., OTSUKA Pharmaceutical
    01 Jan 2011 - 01 Jan 2012 (International)
  • A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of The Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor. Couple: Concomitant Use of Priligy in Men Treated for Erectile Dysfunction, Johnson and Johnson
    01 May 2010 - 01 May 2011 (International)
  • Safety, Tolerability and Treatment Response of Paliperidone Palmitate in Subjects With Schizophrenia When Switching from Oral Antipsychotics-Sustain Study, Johnson and Johnson
    01 May 2010 - 01 May 2011 (International)
  • Zoom Antidepressants Study 009-1003, Cegedim
    01 Apr 2011 - 01 Apr 2011 (National)
  • A 3 Weeks Open Label Study to Evaluate The Efficacy in Agitation and Safety of Quetiapine Fumarate (Seraoquel Xr) in The Treatment of Hospitalised Patients Wuth Acute Schizophrenia, Astra Zeneca
    01 Nov 2009 - 01 Nov 2009 (International)
  • A Prospective, Randomized, Active-Controlled, Rater-Blinded Study of The Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently Diagnosed Schizophrenia Who Are At High Risk of Relapse., Johnson and Johnson
    01 Nov 2009 - 01 Nov 2009 (International)
  • Centre Survey Study, National Mental Health Registry
    01 Nov 2009 - 01 Nov 2009 (National)
  • A 52 Week, Muticenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate The Efficacy, Safety and Tolerability of An Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia "Aspire Us", COVANCE/Otsuka
    01 Nov 2009 - 01 Nov 2009 (International)
  • Lundbeck Study11613a Double Blind Randomised Parallel Group, Placebo Controlled Study of The Safety Tolerability and Efficacy Following Sequential Doses of Lu 31-130 to Male Patients With Schizophrenia, Lundbeck
    01 Nov 2008 - 01 Nov 2008 (International)
  • Perfect Study Sch3022, Janssen Cilag
    01 Nov 2007 - 01 Nov 2008 (International)
  • Efficacy and Safety of Agomelatine With Flexible Dose Given Orally for 8 Weeks in Outpatients With Major Depressive Disorder, Servier
    01 Nov 2007 - 01 Nov 2008 (International)
  • Janssen Ro 76477-Sca 3002 Randomised, Double Blind Placebo Controlled Parallel Group Study to Evaluate The Efficacy and Safety of Flexible Dose Paliperidone Er in The Treatment of Subjects With Schizoaffective Disorder, Janssen Cilag
    01 Nov 2007 - 01 Nov 2008 (International)
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Gorup Comparison Trial of Aripiprazole in The Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode. Protocol 031-06-003, Otsuka
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Investigative Extension Trial of The Safety and Efficacy of Aripiprazole in The Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode. Protocol 031-06-004, Otsuka
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Access The Pharmacokinetics, Safety and Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia, Johnson and Johnson
    01 Nov 2008 - 01 Nov 2008 (International)
  • R092670-Psy-1008 Open Label, Long-Term, Multiple Dose, Safety and Tolerability, Pharmacokinetic Study of 150mg Eq. Paliperidone Palmitate in The Treatment of Subjects With Schizophrenia, Janssen Cilag
    01 Nov 2008 - 01 Nov 2008 (International)
  • Efficcacy and Safety of 2mg/Day of M100907 On Sleep Maintenance Insomnia With a Sub-Study of The Effect of M100907 On Stable Type Ll Diabetes Mellitus: a 12 Week, Multi-Center, Randomised, Double-Blind, Placebo-Controlled Study, Sanofi Aventis
    01 Nov 2007 - 01 Nov 2008 (International)
  • Efficcacy and Safety of 2mg/Day of M100907 On Sleep Maintenance Insomnia With a Sub-Study of The Effect of M100907 On Stable Type Ll Diabetes Mellitus: a One Year, Multi-Center, Randomised, Double-Blind, Placebo-Controlled Study,  Sanofi Aventis
    01 Nov 2007 - 01 Nov 2008 (International)
  • A Randomized Double Blind, Placebo and Active Controlled, Parallel Group Study to Evaluate The Efficacy and Safety of Risperidone Long Acting Injectable for The Prevention of Mood Episodes in The Treatment of Subjects With Bipolar 1 Disorder, Janssen Cilag
    01 Nov 2007 - 01 Nov 2008 (International)
  • Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Duloxetine-Referenced, Dose-Finding Study of Lu Aa24530 in Major Depressive Disorder 2008 - Present, Lundbeck
    01 Nov 2008 - 01 Nov 2008 (International)
  • Zip Peds A1281134/35 Six Week, Double-Blind, Placebo-Controlled Phase Lll Trial Evaluating The Efficacy, Safety and Pharmacokinetics of Flexible Doses of Oral Ziprasidone in Adolescents With Schizophrenia, Pfizer
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Multicenter, Investigative Study of The Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for The Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode. Protocol 031-06-005, Otsuka
    01 Nov 2008 - 01 Nov 2008 (International)
  • A One-Year Multinational, Multi-Centre, Randomised, Double-Blind, Parallel-Group, Fixed-Dose, Bifeprunox Study Combining a 12-Week Placebo-Controlled, Quetiapine-Referenced Phase With a 12-Month Quetiapine-Controlled Phase in Patients With Schizophrenia, Lundbeck/Solvay/Wyeth
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Phase 3 Randomised, Placebo-Controlled, Clinical Trial to Study The Safety and Efficacy of Three Doses of Lorasidone Hcl in Acutely Psychotic Patients With Schizophrenia, Dainippon Sumitomo Pharma America, Inc.
    01 Nov 2008 - 01 Nov 2008 (International)
  • A Prospective, Observational Study Comparing The Frequency of Treatment-Emergent Sexual Dysfunction Over 8 Weeks in Patients With Major Depressive Disorder Treated With Either Duloxetine Hydrochloride or a Selective Serotonin Reuptake Inhibitor Antidepressant and Evaluated for 6 Months, Eli Lilly
    01 Nov 2008 - 01 Nov 2008 (International)
  • Randomised, Double-Blind, Parallel-Group, Placebo-Controlled and Active Referenced Study of Lu Aa34893 to Evaluate The Efficacy and Safety of Three Doses Lu Aa 34893 and Quetiapine Versus Placebo in The Treatment of Depression in Patients With Bipolar L or Ll Disorder, Lundbeck
    01 Nov 2008 - 01 Nov 2008 (International)
  • Pharmacoepidemiological International Longitudinal Antipsychotic Registry (Pilar) Study, Janssen-Cilag
    01 Nov 2008 - 01 Nov 2008 (International)
  • Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Duloxetine Referenced, Fixed Dose Study Evaluating The Efficacy and Safety of Three Dosages of Luaa21004 in Acute Treatment of Major Depressive Disorder, Lundbeck
    01 Nov 2008 - 01 Nov 2008 (International)

PAPER PRESENTED


INVITED SPEAKER
  1. Zeldox IM- The New Option in Agitation Management, Workshop on Updates on Neuropsychopharmacology, HTAR (Others) (18 Nov 2009 - 18 Nov 2009)
  2. Stress Management for Staff, Minggu Kualiti PPUM, Jawatankuasa Kerja Pengurusan Kualiti dan Keselamatan PPUM (University) (10 Nov 2009 - 10 Nov 2009)
  3. Treatment in Bipolar Depression and Maintenance Therapy, REACH Workshop-Toward a better understanding of mood disorders, Astra Zeneca in collaboration with UMMC and UKMMC (University) (03 Oct 2009 - 03 Oct 2009)
  4. Medical Conditions and treatments associated with psychiatric disorders, Consultation Liaison Psychiatry Seminar, Department of Psychological Medicine, UM (University) (15 Jul 2009 - 15 Jul 2009)
  5. What is liaison psychiatry and what we do?, Consultation Liaison Psychiatry Seminar, Department of Psychological Medicine, UM (University) (15 Jul 2009 - 15 Jul 2009)
  6. Treatment Effectiveness EBM, Eli Lilly lunch symposium, Eli Lilly (01 Apr 2009 - 01 Apr 2009)
  7. Depression in Physical Illness, Workshop in Consultation Liaison Psychiatry, Department of Psychological Medicine, University Malaya (14 Feb 2009 - 14 Feb 2009)
  8. Case Studies on Major Depression with Anxiety, Workshop on Updates on Major Depression, Wyeth (University) (09 Aug 2008 - 09 Aug 2008)
  9. Neurobiology of Depression, Updates on Management of Chronic Pain, UPM  (University) (07 Aug 2008 - 07 Aug 2008)
  10. Generalised Anxiety Disorder, Eli Lilly midyear workshop, Eli Lilly (Others) (21 Jul 2008 - 21 Jul 2008)
  11. Importance of Managing Pain in Major Depressive Disorder, Eli Lilly Symposium, Eli Lilly (Others) (02 Jul 2008 - 02 Jul 2008)
  12. Case Study on Violent Patients, Violence Intervention Workshop, University Malaya/Pfizer (National) (21 Jun 2008 - 21 Jun 2008)
  13. Neurobiology of Depression, Depression and Pain Workshop, Eli Lilly (Others) (02 Feb 2008 - 02 Feb 2008)
  14. Bipolar Affective Disorder: A Malaysian Experience, Ist Council Meeting of the Asian Network of Bipolar Disorder(ANBD), Asian Network of Bipolar Disorder (International) (15 Nov 2007 - 16 Nov 2007)
  15. Stress Management, Workshop on Stress Management, Department of Psychological Medicine (University) (15 Sep 2007 - 15 Sep 2007)
  16. Stress Management, Workshop on Stress Management, Department of Psychological Medicine (University) (25 Aug 2007 - 25 Aug 2007)
  17. Major Depression, Total Women Health workshop, Wyeth (Others) (15 Jul 2007 - 15 Jul 2007)
  18. Lamictal, the stabilizing force for bipolar disorder, Updates on Bipolar Disorder, GSK (Others) (29 Mar 2007 - 29 Mar 2007)
  19. -, Update on Psychiatric Treatment, Department of Psychological Medicine (Others) (13 Feb 2007 - 13 Feb 2007)
  20. Relapse Prevention in Schizophrenia, Schizophrenia Awareness Day, Malaysian Mental Health Foundation  (National) (14 Aug 2006)
  21. -, Site Initiation Meeting for AMBER Study, Astra Zeneca (Others) (19 Jun 2006 - 19 Jun 2006)
ORAL PRESENTER
  1. Efeectiveness of Electroconvulsive Therapy Use in Mood Disorders and Psychosis in University Malaya Medical Center, First International Review of Bipolar Disorders Asia Pacific 2008, IRBD (International) (25 Nov 2008 - 25 Nov 2008)
POSTER PRESENTER
  1. Post-stroke mania: A case report, 3rd Biennial Conference of the International Society for Bipolar Disorders, International Society for Bipolar Disorders (International) (26 Jan 2008 - 26 Jan 2008)
PRESENTER
  1. Investigative Site Breakout: Maximizing Patient Flow Workshop, ASPIRE Investigator Meeting, Janssen Pharmaceutical Companies of Johnson and Johnson (International) (13 Jul 2017 - 15 Jul 2017)
  2. Identifying and Managing Early Psychosis, Early Psychosis Awareness Programme, Dr. Koh Ong Hui via Circle of Care, MPA (Others) (26 Jun 2009 - 26 Jun 2009)
  3. Long Essay Group Work, Workshop for Conjoint Postgraduate Examiners, USM (University) (12 Jan 2009 - 13 Jan 2009)
  4. ANBD: The Next Step Toward 2020, 1st Asian Network of Bipolar Disorder ANBD) Conference , ANBD and Astra Zeneca (International) (26 Aug 2008 - 26 Aug 2008)
  5. Smoking And Its Hazards, Health Education, 3TE Ward (Others) (03 Jun 2008 - 03 Jun 2008)
  6. MADRS Training for Malaysia and Indonesia, Asia Pacific Investigator\'s Meeting, Lundbeck (International) (28 Feb 2008 - 28 Feb 2008)
  7. FEARSOME Study, Workshop on Conjoint Research Initiatives, UM/UKM/USM (University) (23 Oct 2007 - 24 Oct 2007)
OTHERS
  1. Menarini Psychiatry in Action, Chairperson, Menarini (National) (13 Oct 2017 - 14 Dec 2017)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2024) Impact of Yoga and Naturopathy On Stress, Anxiety, Heart Rate Variability and Quality of Life of a Patient With Social Anxiety Disorder: a Case Report, National, (Reviewer)
  2. (2023) Secondary Amenorrhea Associated With Vortioxetine in The Treatment of Major Depressive Disorder, National, (Reviewer)
  3. (2023) External Examiner for Undergraduate Examinations for Upnm, National, (External Examiner)
  4. (2023) Autism and Attention Deficit Hyperactivity Disorder Symptoms Amongst High Iq Youths and Associated Psychological Comorbidities, University, (Reviewer)
  5. (2023) An Investigation of Mental Health, Organisational Factors, Employee Wellbeing and Its Impact On Employer Brand Equity and Employee Retention, University, (Reviewer)
  6. (2023) Factors Affecting Post-Traumatic Stress Disorder Among Adolescents in Picu: a Mixed Method Study, International, (Reviewer)
  7. (2023) Trauma-Related Hallucination in 8-Year-Old Child, With Dissociative Symptoms: a Case Report, National, (Reviewer)
  8. (2023) Effect of Listening Religious Music: Basic Mindfulness Based Stress Reduction (Mbsr) Related Stress, Anxiety and Burnout Among Critical Care Nurses in Teaching Hospital, University, (Reviewer)
  9. (2023) Acceptance and Commitment Therapy (Act) for The Management of Youth Suicide, University, (Reviewer)
  10. (2023) A Study On Attitudes Towards Suicide, Psychological Distress and Suicidal Behaviour Among Students in a Public University in East Malaysia, National, (External Examiner)
  11. (2023) 'Gaming Over?: a Systematic Review of The Psychology of Gaming Addiction'., National, (Reviewer)
  12. (2022) Effects of Dementia Behavioral Educational Program On Caregiver Burden, Self-Efficacy and Mental Health of Carers, University, (External Assessor)
  13. (2022) The Effects of Mindful Exercise On Physical and Psychological Consequences of Primary Osteoporosis in Older Patients, International, (External Assessor)
  14. (2022) The Effect of Online Psychoeducation Program On Panic Symptom Severity, Anxiety and Quality of Life Among People Experiencing Panic Attacks in Egypt, International, (External Assessor)
  15. (2022) 'Negative Symptoms of Schizophrenia: to Be in-Patient or Out-Patient? a Clinical Experience.', National, (Reviewer)
  16. (2022) 'Prevalence of Depression, Anxiety and Stress Among Medical University Lecturers in Malaysia During Covid-19 Pandemic'., National, (Reviewer)
  17. (2016) Cognitive dysfunction in psychiatric patients: Comparison between schizophrenic and bipolar disorder patients with healthy controls, (Internal Examiner)
  18. (2016) The Role of Psychiatric Posting in Influencing Medical Students' Attitudes Towards Mental Illness: A Comparison Between the Old and New Syllabus , (Internal Examiner)
  19. Bipolar Disorders Audio CD Psychoeducation Kit
  20. ADHD Audio CD Psychoeducation Kit
  21. Socio-economic Cost of Schizophrenia Treatment Bulletin Report
  22. ‘Bipolar Affective Disorder and Quetiapine’ in Medical Grapevine Magazine
  23. PANSS Interview Training Video for Clinical Research for Schizophrenia
  24. Dementia audio CD psychoeducation kit
  25. Anxiety Disorders Audio CD Psychoeducation Kit
Contribution to external organisation
  1. (2024) Pelantikan Sebagai Panel Pakar Penasihat Pihak Berkuasa Kawalan Dadah (Pbkd), National, (Expert Advisor)
  2. (2023) Lawatan Pelajar Perubatan Posting Psikiatri Tahun 4 Fakulti Perubatan Uitm Ke Pusat Rawatan Harian Ppum, National, (Adjunct/Visiting Professors)
  3. (2022) Restart Clinic, National, (Resource Person)
  4. (2007) Council Member, Asian Network Of Bipolar Disorder, International
  5. (2007) PANSS Interview Training Video for Clinical Research on Schizophrenia , Lundbeck
  6. (2006) Audio CD Patient Psychoeducation Kit for Bipolar Disorder , Eli Lilly
  7. (2006) Audio CD Patient Psychoeducation Kit for ADHD, Eli Lilly
  8. (2006) Audio CD Patient Psychoeducation Kit for Dementia, Eli Lilly
  9. (2006) Audio CD Patient Psychoeducation Kit for Anxiety Disorder, Pfizer
Contribution to event
  1. (2024) Seroquel Xr's Symphony in Bipolar Disorder, International, (Panelist/Moderator)
  2. (2023) Hope for Trd & Mdsi With Spravato, National, (Panelist/Moderator)
  3. (2023) Short Case Practice and Tips for Examination, National, (Panelist/Moderator)
  4. (2023) Clinical Management of Anxious Depression, National, (Panelist/Moderator)
  5. (2023) Role of 3 Monthly-Lai in Schizophrenia Management, National, (Panelist/Moderator)
  6. (2023) Generalized Anxiety Disorder-The Disease, National, (Panelist/Moderator)
  7. (2022) Hope for Trd and Mdsi Patients With Spravato, International, (Panelist/Moderator)
  8. (2022) Optimising Treatment Outcome in Bipolar Disorder, National, (Panelist/Moderator)
  9. (2022) Clinical Management of Anxious Depression, National, (Panelist/Moderator)
  10. (2022) Depression and Anxiety in The Covid Pandemic, National, (Panelist/Moderator)
  11. (2022) Functional Recovery for Young Adults Through Anhedonia Improvement in Mdd Treatment, National, (Panelist/Moderator)
  12. (2022) A Paradigm Shift in Mdd: from Symptom Improvement to Full Functional Recovery, National, (Panelist/Moderator)
  13. (2022) Switching to Quetiapine Xr Now, International, (Panelist/Moderator)
  14. (2022) Spravato: Breakthrough Treatment for Mdd With Acute Suicidal Ideation and Behaviour (Mdsi) & Treatment Resistant Depression (Trd), National, (Panelist/Moderator)
  15. (2022) Malaysian Psychiatric Association Quickfire Viva Voce, National, (Panelist/Moderator)
  16. (2022) Treatment Options for Major Depressive Disorder, National, (Panelist/Moderator)
  17. (2021) Invega Trinza: Improving Clinical Outcomes, National, (Panelist/Moderator)
  18. (2021) Role and Benefits of Pp3m: The Way Forward, National, (Panelist/Moderator)
  19. (2021) Treatment Continuity for Functional Recovery in Depression, National, (Panelist/Moderator)
  20. (2021) Mental Health and Community Psychiatric Services in Malaysia, International, (Panelist/Moderator)
  21. (2021) Webinar for Mental Health Awareness Week, University, (Event Organiser)
  22. (2021) Managing Emotional and Mental Health, National, (Panelist/Moderator)
  23. (2021) Spravato : from Research to Clinical Practice for Treatment Resistant Depression, National, (Panelist/Moderator)
  24. (2021) Invega Trinza: Changing The Schizophrenia Treatment Landscape, National, (Panelist/Moderator)
  25. (2021) Treatment Options in Depression, University, (Panelist/Moderator)
  26. (2021) Therapeutic Solutions to Engage Depressed Patients in Treatment Continuity, National, (Panelist/Moderator)
  27. (2021) Changing The Schizophrenia Treatment Landscape With Invega Trinza, University, (Panelist/Moderator)
  28. (2021) Escitalopram in Anxiety Disorders, University, (Panelist/Moderator)
Media appearance
  1. (2023) World Mental Health Day 2023 Seminar/Introduction to Anxiety Disorders, University, (Panelist/Moderator)

SUPERVISION


Postgraduate Student
Master
  1. (2017) Ward Supervisor, Lim Kuok Quen
  2. (2017) Permanent Supervisor, Sivabalan Panikkar a/l Rajandran
  3. (2017) Permanent Supervisor, Lim Poh Khuen
  4. (2017) First Episode Psychosis, Mohd Miharbei Bin Mohd Firdaus
  5. (2017) Cognition in Schizophrenia, Normala binti Sorikan
  6. (2016) Permanent Supervisor, Minoovelasri A/P M. Ponnuthurai
  7. (2015) Ward supervisor, Sughashini a/p Subramaniam
  8. (2015) Ward supervisor, Norsuhana Bt Sainal
  9. (2015) Ward supervisor, Marini Bt Nawal
  10. (2015) Ward supervisor, Devaki A/P Sathiaray
  11. (2015) Ward supervisor, Angelvene Wong Yin Tze
  12. (2015) Schizophrenia case protocol, Ishwary a'p Damodaran
  13. (2015) Permanent Supervisor, Sridaran a/l Pawadei@Ganesan
  14. (2015) Permanent Supervisor, Ishwary a'p Damodaran
  15. (2015) Community Psychiatry Case Protocol, Sylvia Wong Tyng Yng
  16. (2015) Community Psychiatry Case Protocol, Chin Han Lim
  17. (2015) Community Psychiatry Case Protocol, Angelvene Wong Yin Tze
  18. (2015) Community Psychiatry Case Protocol, Abdul Rasyid bin Sulaiman
  19. (2015) Anxiety Disorder Case Protocol, Ishwary a'p Damodaran
  20. (2010) Ward supervisor, Ng Teng Khai
  21. (2010) Scizophrenia Case Protocol, Nur Adilah Binti Sulaiman
  22. (2010) Permanent Supervisor, Nur Adilah Binti Sulaiman
  23. (2010) Generalized Anxiety Disorder Case Protocol, Nur Adilah Binti Sulaiman
  24. (2009) Schizophrenia case protocol, Norley Shuib
  25. (2009) Psychological Medicine attachment for Masters in Family Medicine, Dr. Julia Suhaimi, Dr. Nurainul Hana Shamsudin
  26. (2009) Permanent Supervisor, Tan Lee Khing
  27. (2009) Panic Disorder, Tan Lee Khing
  28. (2009) Masters in Family Medicine, Dr. Tun Firzara Abdul Malik
  29. (2009) Masters in Family Medicine, Dr. Siti Nurkamilla Ramdzan
  30. (2009) Masters in Family Medicine, Dr. Salinah bt Mohd Mudri
  31. (2009) Masters In Family Medicine, Dr. Maliza Mawardi
  32. (2009) Anxiety Disorder case protocol, Norley Shuib
  33. (2008) Ward Supervisor, Tan Chea Loon
  34. (2008) Ward Supervisor, Shirin Mirzazadeh
  35. (2008) Ward Supervisor, Sareh Alavirad
  36. (2008) Permanent Supervisor, Dr. Nazariah Aiza bt Harun
  37. (2008) Case protocol for mood disorder, Nazariah Aiza Binti Harun
  38. (2008) Anxiety Disorder with Comorbid Depression, Nazariah Aiza binti Harun
  39. (2007) Ward Supervisor, Wah Kheng Yee
  40. (2007) Ward supervisor, Khatijah Kasmuri
  41. (2007) Ward supervisor, Gurdeep Singh a/l Narain Singh
  42. (2007) Ward Supervisor, Abdul Malik Muhammad Saeed
  43. (2007) Schizophrenia, Dr. Nurul Azreen Hashim (University of Malaya (UM))
  44. (2007) Psychotic Disorder due to Neurosyphilis, Nurul Azreen Hashim
  45. (2007) Permanent supervisor, Nurul Azreen Hashim (University of Malaya (UM))
  46. (2007) Organic Brain Syndrome, Dr. Saniah Abdul Rahim (University of Malaya (UM))
  47. (2007) Major Depressive Disorder, Anne Yee Hway Ann
  48. (2007) Epilepsy with Psychosis, Dr. Nurul Azreen Hashim (University of Malaya (UM))
  49. (2007) Attachment in Psychological Medicine, Dr. Lee Yeow Siong
  50. (2007) Anxiety Disorder, Dr. Saniah Abdul Rahim (University of Malaya (UM))
  51. (2006) Ward Supervisor, Anne Yee Hway Ann
  52. (2006) Schizophrenia, Dr. Tiong Chea Ping (University of Malaya (UM))
  53. (2006) Panic Disorder Without Agoraphobia, Dr. Tiong Chea Ping (University of Malaya (UM))
Under Graduate Students
  1. (2009) Medical undergraduates from unscheduled universities
  2. (2007) Elective posting in the Department of Psychological Medicine from Russia Stete Medical University and Moscow Medical Academy
  3. (2007) Diploma in Psychology
  4. (2006) MBBS

TEACHING


Master
  1. (2022) MPM - Master of Psychological Medicine
  2. (2021) - - Master of Psychological Medicine
  3. (2008) MPM - Masters in Psychological Medicine
  4. (2006) Masters in Psychological Medicine
  5. (2005) Masters in Psychological Medicine
  6. (2004) Masters in Psychological Medicine
Bachelor
  1. (2022) UMMP - Examiner of Eop Stage 3.3
  2. (2021) UMMP - Universiti Malaya Medical Programme

SOCIAL RESPONSIBILITY ACTIVITIES


  • 6th Sea Neuroscience Conference Organising Committee, (01 Aug 2009 - 02 Aug 2009)
  • Early Psychosis Awareness Programme, (26 Jun 2009 - 26 Jun 2009)
  • Asia Pacific Investigator'S Meeting, (28 Feb 2008)
  • Depression and Pain Workshop, (02 Feb 2008)
  • "Post-Stroke Mania: a Case Report", 3rd Biennial Conference of The International Society for Bipolar Disorders, Delhi, India, (27 Jan 2008)
  • "Bipolar Affective Disorder-a Malaysian Perspective", !St Council Meeting of The Asian Network of Bipolar Disorder(Anbd), Hong Kong, (15 Nov 2007)
  • Workshop On Conjoint Research Initiatives, (23 Oct 2007)
  • Workshop On Stress Management, (15 Sep 2007)
  • Workshop On Stress Management, (25 Aug 2007)
  • Total Women Health Workshop, (15 Jul 2007)
  • Interview for Tv2 Health Documentary Entitled Infopsikik, (01 May 2007)
  • Lamictal, The Stabilizing Force for Bipolar Disorder, (29 Mar 2007)
  • Update On Psychiatric Treatment, (13 Feb 2007)
  • "Relapse Prevention in Schizophrenia", Schizophrenia Awareness Day, Hotel Putra Kl, (14 Aug 2006)
  • "Cost of Treating Schizophrenia in a Teaching Institution", Secost Meeting, Pj Hilton, (03 Jun 2006)
  • Bipolar Affective Disorder, Attention Deficit Hyperactive Disorder, Dementia and Anxiety Disorders Audio Cd Psychoeducation Kit, (01 Jun 2006)
  • "Benzodiazepine Dependence Syndrome", Gp Workshop , Cherating, Pahang, (22 Apr 2006)
  • "Stress Management", Dental Faculty, Ummc, (05 Apr 2006)
  • "Introduction to Schizophrenia", Pfizer Malaysia Headquarters, (10 Jan 2006)
  • "Relationship of Physical and Psychological Illness", Seminar for World Mental Health Day , Hospital Mesra Bukit Padang, Sabah, (10 Oct 2004)